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Abstract 
 
Background:  Suspected poisoning is a common cause of hospital admission internationally. 
In the United Kingdom, the National Poisons Information Service (NPIS), a network of four 
poisons units, provides specialist advice to health professionals on the management of 
poisoning by telephone and via its online poisoning information and management database, 
TOXBASE®. 
 
Objective: To demonstrate the impact of NPIS telephone advice and TOXBASE® guidance 
on poisoning-related referrals to emergency departments (ED) from primary health care 
settings. 
 
Methods: A telephone survey of primary healthcare providers calling the NPIS and an online 
survey of TOXBASE® primary care users were conducted to evaluate the effect of these 
services on poisoning related ED referrals.  Enquirers were asked to indicate whether referral 
was needed before and after using these information sources. 
 
Results: The number of cases considered by enquirers appropriate for ED referral was 
reduced from 1178 (58.1%) before to 819 (40.4%) after provision of telephone advice for 
2028 cases (absolute reduction 17.7%, 95% CI 14.6, 20.7%) and from 410 (48.2%) before to 
341 (40.1%) after consideration of  TOXBASE® guidance for 851 cases (absolute reduction 
8.1%, 95% CI 3.3, 12.9%). By extrapolating these figures over a full year, it is estimated that 
these services prevent approximately 41,000 ED referrals annually. 
 
Conclusions: The use of NPIS services significantly reduced ED referrals from primary 
healthcare services with resulting avoided healthcare costs exceeding the current annual NPIS 
budget. Further studies are needed to evaluate other potential benefits of accessing NPIS 
services.  
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 Introduction: 
 
Poisoning, actual or suspected, is common. In the United Kingdom (UK) there are more than 
170,000 poisoning-related hospital admissions annually [1], contributing approximately 1% 
of all hospital admissions [2,3]. Hospital admissions and deaths related to poisoning and drug 
abuse have increased over the last decade [4,5]. Suspected poisoning therefore presents a 
considerable workload for primary and secondary care. 
 
In the UK, the National Poisons Information Service (NPIS), a network of 4 poisons units, 
provides information and evidence-based management advice about poisoning to health 
professionals. This is available via the online toxicology database, TOXBASE®, the related 
TOXBASE® app for mobile devices [6] and a 24-hour telephone advice service staffed by 
trained Specialists in Poisons Information (SPIs) supported by an on-call rotation of 
consultant clinical toxicologists. The NPIS aims to provide the required expertise to avoid 
unnecessary hospital referrals and admissions for patients at low risk of harm, while 
improving the quality of treatment and shortening hospital stay for those at risk of clinical 
toxicity [1]. The NPIS is commissioned by Public Health England (PHE) on behalf of all UK 
Health Departments. 
 
Common users of the telephone enquiry service and of TOXBASE® include hospitals, 
particularly ED, and primary healthcare organisations including general practitioners (GPs), 
walk-in health centres, ambulance services, prison staff and public access healthcare 
telephone advice services (NHS 111 in England [7], NHS Direct in Wales [8] and NHS 24 in 
Scotland [9]). The NPIS received approximately 48,000 telephone enquiries in the 2015/16 
fiscal year (April to March). Over the same period, the NPIS online database TOXBASE® 
registered nearly 609,000 user sessions and 1.69 million separate page views of TOXBASE® 
entries [1]. 
 
Studies done in other countries have demonstrated the cost-effectiveness of poisons centres, 
but such studies have not previously been conducted in the UK. One of the major potential 
benefits of poisons centres is that the advice they provide may allow some patients who 
would otherwise be referred to an ED to be treated at home. This improves the quality and 
convenience of care for patients and also reduces healthcare costs. This study was therefore 
performed to determine the impact of NPIS telephone and TOXBASE® advice on rates of 
ED referral after enquiries from primary care and to estimate the cost impact of the advice 
provided.  
Methods: 
 
This study was performed as a service evaluation and as such approval from a research ethics 
committee is not required in the United Kingdom. 
 
Telephone survey: 
All four NPIS units participated in a prospective telephone survey, although they did not all 
start on the same date due to different on call allocations and requirements for local 
preparation. The NPIS units in Newcastle upon Tyne and Cardiff started data collection on 4th 
January 2016 and those in Edinburgh and Birmingham on 13th January and 20th January 2016 
respectively. All four NPIS units completed data collection at midnight on 19th February 
2016 so units collected data over 31 to 47 days. 
  
Callers to the NPIS telephone advice line from NHS primary healthcare professionals treating 
or managing a patient with confirmed or suspected exposure to poisoning were invited to 
participate. This involved a two-question telephone survey to determine patient management 
in the absence of the NPIS advice service and changes in the proposed management 
following consulting the service. Calls from hospitals (secondary care settings), the Republic 
of Ireland, or those that did not relate to management of a specific patient were excluded. 
 
Enquirers were asked to choose their planned course of management prior to receiving NPIS 
telephone advice or reading TOXBASE®. After receiving the relevant NPIS advice or 
reading TOXBASE®, the enquirers were asked again to choose their planned course of 
management.  Referral options were: (1) Attend a Hospital ED; (2) Refer to a General 
Practitioner (GP); (3) Refer to a pharmacy or (4) home observations only. The text of the 
script used by the SPI is provided in the on-line supplementary material  
 
The survey was conducted by NPIS SPIs and responses were entered into the free comments 
section of the online UK Poisons Information Database (UKPID) database using unique 
codes with capitalised letters. These were later extracted onto a Microsoft Excel® 
spreadsheet from which the total number of registered responses and breakdown of these 
responses were analysed.  
 
Incomplete, unclear or inaccurate responses were identified and reviewed by a physician and 
an experienced SPI. Recorded responses determined to have clear information indicating the 
observed outcomes were accepted. The total number of eligible calls to for inclusion into the 
study was extracted by reviewing UKPID. 
 
 
 
TOXBASE® survey: 
During the period 9th May to 14th June 2016, TOXBASE® users from primary healthcare 
services were invited to participate in a two-question survey via a pop-up box, which 
appeared to primary care but not secondary care users accessing a product page. Users were 
asked to choose their planned course of management prior to and again after accessing 
TOXBASE® advice and information. The same referral options were used as in the 
telephone survey. Text used in the pop-up box is provided in the supplementary material.  
 
The extracted results were transferred onto a Microsoft Excel® spreadsheet, which was 
analysed to assess completed responses.  
 
Data analysis 
Statistical significance was assessed by calculating percentage absolute changes in referrals 
to each referral option and the respective 95% confidence intervals after use of the telephone 
service or TOXBASE. Differences in proportions of patients referred before and after use of 
these services was also compared by chi square testing using the Yates continuity correction, 
with P < 0.05 considered statistically significant. 
 
To calculate potential cost savings made from avoided ED attendances, the 2014-2015 UK 
National Health Service (NHS) reference cost of £156.64 for a typical poisoning related ED 
attendance (HRG4 code VB08Z) [10-13] was used.  The lowest cost tariff from the 2015 UK 
General Practitioner Unit Costs [14] was used to calculate potential cost savings from 
avoided GP referrals.  
 
The total number of avoided patient referrals was extrapolated based on the number of patient 
specific telephone enquiries received by the NPIS during the 2015/16 financial year. 
 
Sensitivity analyses 
Sensitivity analyses were conducted of the NPIS telephone survey data by classifying 
Enquiries according to time received and PSS of enquiry. These subgroups were compared to 
identify potential differences or bias in recorded referral plans related to timing or PSS of 
enquiry.  
 
Extrapolated annual referral figures were calculated based on the numbers of NPIS telephone 
enquiries received during the 2015/16 financial year as registered on UKPID and  classified 
according to time received and PSS. 
Results: 
 
NPIS telephone enquiries survey: 
There were 3916 telephone enquiries meeting the study inclusion criteria, but 152 callers 
(3.9%) declined to participate, 140 cases (3.6%) had incorrectly or ambiguously coded 
responses and 1596 (40.8%) enquirers were not asked the two study questions, usually 
because of concurrent pressures on service provision. Therefore, 2028 completed responses 
were recorded (Figure 1 and Table 1).  The largest group taking part in the survey were staff 
of publically accessible health advice telephone lines (e.g. NHS 111), but general 
practitioners and ambulance service staff were also commonly involved (Table 1). 
 
 [Table 1 near here] 
 
Of all completed responses, 962 (47.4%) and 829 (40.9%) concerned patients under the age 
of 16 and 6 years of age respectively. There were 994 (49%) responses related to enquiries 
made outside normal office hours, of which 456 (45.9%) related to children aged 0 to 16 
years.  
 
In the absence of the NPIS telephone advice service, callers reported that they would have 
referred 1178 (58.1%) of the 2028 patients to an ED. Other planned referral routes included 
to a general practitioner (515, 25.4%) or a pharmacy (59, 2.9%), while home observations 
were considered appropriate for 276 (13.6%) patients (Table 2). Following NPIS telephone 
advice, changes in planned management included a reduction in ED (17.7%, 95% CI 14.6-
20.7), GP (15.3%, 95% CI 12.9-17.6) and pharmacy (2.6%, 95% CI 1.8-3.5) referrals (Table 
2). These overall figures are net changes incorporating a smaller number of cases where NPIS 
advice lead to upgrading of the planned referral, e.g. 119 patients referred to an ED rather 
than a GP and 55 patients referred to an ED and 12 to a GP instead of for home care. (Table 
2) 
 
[Table 2 near here] 
 
During the 2015/16 financial year, 46,885 patient specific telephone enquiries were received 
by the NPIS, including 33,859 from primary care. Extrapolating the changes described here 
in intended referral routes across a whole year suggests that provision of NPIS telephone 
advice avoids almost 6,000 ED visits and 8,600 GP referrals. Based on the 2014-2015 NHS 
reference cost of £156.64, NPIS telephone advice to primary care users provided an estimated 
saving of £939,000 annually in terms of net reductions in ED attendances.  Using the lowest 
cost tariff, GP referrals avoided as a result of NPIS telephone advice are estimated to save 
approximately £228,000 annually in addition. 
 
These estimates, however, assume that the proportion of ED visits avoided was not affected 
by the severity of poisoning or the time of day of the enquiry, but there were differences in 
these characteristics between calls with and without recorded survey responses. Calls with 
recorded survey responses had a reduced proportion received outside normal office hours 
(994/2028 [49.1%] vs. 900/1596 [56.5%], difference 7.4% [95% CI: 4.1-10.7]),  a higher 
proportion with a Poison Severity Score (PSS) of 0 (no symptoms) [15]   (1556/2028 [76.7%] 
vs 1148/1596 [69.2%], difference 4.8% [95% CI 1.9-7.7]) and a lower proportion with a PSS 
of 1 (minor symptoms) (418/2028 [20.6%] vs 375/1596 [23.5%], difference 2.8% [95% CI 
1.3-5.7]). ED referral was avoided in a higher proportion of enquiries received during normal 
office hours and when the PSS was 0 or unclassified (Table 3). As these are circumstances 
when survey responses were more likely to be received, the overall savings in ED visits and 
costs described above will be overestimated. To correct for this, separate estimates were 
performed for each of 4 groups and these were then summed (Table 3). This reduced the 
annual number of estimated ED referrals avoided from 5994 to 5643 and the estimated ED-
related cost saving from £939,000 to £884,000. 
 
[Table 3 near here] 
TOXBASE® Survey: 
During the period of study, 31,151 TOXBASE® page loads from primary healthcare users 
were registered, but survey questions were answered for only 851 (2.7%) of these. 
 
In the absence of TOXBASE® advice, 410 respondents (48.2%) would have referred the 
patient to an ED, 175 to a GP (20.6%) and 19 to a Pharmacy (2.2%), with 247 respondents 
opting for home care (29%). Following use of TOXBASE®, cases considered appropriate for 
ED referral reduced to 341, an absolute reduction of 8.1% (95% CI 3.3, 12.9). Use of 
TOXBASE® did not significantly affect GP (absolute reduction 1.8%, 95% CI -2.1, 5.6) or 
pharmacy (0.7%, 95% CI -0.7, 2.2) referrals, although a significant increase in patients 
considered suitable for home care was observed (10.6%, 95% CI 6, 15). As in the telephone 
survey, the figures also incorporate those cases where access to TOXBASE® led to 
upgrading of the planned referral (Table 4). 
 
[Table 4 near here] 
 
The numbers of TOXBASE® accesses from primary healthcare services and users during the 
2016/17 financial year was 427,568.  From this figure, the net annual number of avoided ED 
referrals is estimated as 34,600. Based on NHS reference costs, this translates into an 
estimated annual saving of approximately £5.4M.  
Discussion: 
These surveys involving primary care users of NPIS telephone advice and TOXBASE® 
suggest that provision of NPIS advice substantially reduces ED referrals of patients assessed 
in primary care for suspected or confirmed poisoning and increases the numbers of those 
considered suitable for home care. NPIS telephone advice also reduced referrals to general 
practitioners and pharmacies, although reductions were not statistically significant for 
TOXBASE®. Many of these referrals related to children or occurred outside normal office 
hours, circumstances when the avoidance of unnecessary referral is especially important.  
 
The cost effectiveness of poisons centres and the impact of the telephone advice they provide 
on emergency admissions has been reported previously, for example in studies performed in 
the USA and Singapore [15-21]. In these countries, enquiries are taken from the general 
public as well as health professionals so the impact cannot necessarily be extrapolated to 
services where enquiries are only accepted from health professionals, such as in the UK. We 
are not aware of previous research studying the impact of health-professional only services 
on ED referral patterns. The research presented here, however, demonstrates that use of the 
NPIS telephone advice service in the UK by health professionals prevents many potentially 
unnecessary hospital referrals to ED and general practitioners.  
 
In the UK, health professionals can also obtain advice on managing patients with suspected 
poisoning by accessing the NPIS on-line poisons database TOXBASE®. This route is now 
used substantially more often than the telephone advice facility. To get an accurate 
assessment of the impact of the NPIS it is therefore essential to study the impact of 
TOXBASE® on referral patterns. The data presented here also demonstrates a potential 
reduction in referral intentions after use of this resource. Although the reduction was smaller 
in relative terms, the numbers of ED referrals estimated to be avoided was much larger 
because of the substantially larger numbers of enquiries made via this route than by 
telephone. The proportion of ED referrals avoided was higher after use of the telephone 
service rather than TOXBASE. This may reflect the value of input from a trained specialist in 
poisons information with specific information about the case being referred, as opposed to 
interpretation of text on TOXBASE written to cover all potential scenarios by less 
experienced health professionals. 
 
The net effect from use of NPIS telephone and TOXBASE® services is a considerable 
reduction in ED referrals, as well as smaller reductions in referrals to general practitioners or 
pharmacies. There are considerable benefits to patients, especially children, from avoiding 
unnecessary and potentially distressing referrals, especially as these are likely to result in 
unnecessary examinations, investigations and worry.  The potential financial savings are also 
considerable; using conservative tariff costs and ignoring other associated costs (transport to 
hospital etc.), the estimated financial saving from these reduced referral numbers was 
approximately £6.4M, which exceeds the overall NPIS budget, currently approximately 
£3.5M. These savings relate to hospital costs and do not take into account other savings from 
reduced ED referrals, such as ambulance costs or time away from work for carers. 
Furthermore, this analysis does not take account of many other potential cost-benefits of the 
NPIS which were not evaluated in this research. Examples include possible reductions in 
admission after ED attendance, improved quality of care resulting in better clinical outcomes, 
shortened hospital stay in those admitted and reduced loss of earnings from time off work. 
 
Limitations and strengths 
The most important limitation is the incomplete response rate obtained in both the telephone 
and especially the TOXBASE® study, raising the possibility that those who responded to the 
survey might not reflect the overall population of service users. The incomplete telephone 
survey is not unexpected as it is very challenging for poisons centre staff to administer 
surveys at times of high demand; a similar US poison centre survey conducted on post-
telephone consultation basis had a survey completion rate of 47.1% [22].  
 
In our study, there were small differences in the characteristics of calls with and without 
recorded survey responses, with the former being more likely to occur during normal office 
hours and to concern a patient with a PSS of 0 (no symptoms). These are subgroups where 
referral to an ED is less likely to be necessary, so the study may overestimate the total 
numbers of ED referrals avoided. We were able to correct for that by calculating savings 
separately for each subgroup; this made only a small difference to the estimated savings. We 
cannot exclude the possibility that other biases might arise from the incomplete data 
collection. 
The very low response to the on-line service evaluation mirrors other studies using this 
platform [23,24].  Improving response rates is difficult because it would be inappropriate to 
prevent users from bypassing the survey questions to get to the information they need. No 
patient data are required to access TOXBASE®, so it is not possible to compare patient 
characteristics between those where the study questions were or were not answered. The 
possibility of bias introduced by the low response rate cannot therefore be excluded. We can 
say, however, that the proportion of TOXBASE® accesses during normal office hours in our 
study (32%) is not substantially different from the proportion of registered TOXBASE® 
accesses during normal office hours for the 2016-17 fiscal year (31%). 
The TOXBASE® survey numbers reported are not strict patient numbers or specific logins 
but page load counts. Therefore, a user may potentially generate a duplicate count if the page 
has been refreshed or reviewed more than once. A single user may need to access more than 
one product page for multiple agent exposures and this might result in an overestimation of 
the numbers of patients involved. However, it is more likely that the majority of such 
presentations are referred for further review or hospital admission, especially as general 
guidance recommends referral for multiple agent exposures. As the study survey was 
conducted using a simple “no extra cost” IT platform, the amount of specific and detailed 
information that could be collected was limited.  
The telephone survey was conducted by NPIS SPIs, thus there is a risk of recording and 
researcher bias. However, a major effect seems unlikely as the callers surveyed were not 
aware of the primary hypothesis of the study and the telephone advice provided by the SPIs is 
standardised and governed by evidence-based guidelines. In support of unbiased reporting, 
the referral intent was upgraded for a number of referrals, e.g. to ED referral rather than home 
observation.   The possibility of acquiescence bias, where respondents might answer the 2nd 
survey question in a manner that would be exactly the same as NPIS advice should also be 
considered, particularly if in favour of avoiding a hospital admission. However, the wording 
of the survey was designed to avoid exposing the aims of the study to the callers. Callers 
were advised that the SPIs were undertaking a service evaluation exercise for the NPIS and 
that this was not an assessment of their performance, management or the service they 
represented. Likewise the order of the 4 answers with the most expensive /intensive option 
mentioned first, rather than the target outcome, helped prevent any response order bias; 
although there is a potential for question order bias because of the flow of the 2 questions.  
 
This study also has a number of strengths. Both NPIS telephone and TOXBASE® surveys 
were carried out in a prospective manner and in real time and real world conditions. 
Telephone enquiries meeting the study inclusion criteria were similar in characteristics to 
NPIS enquiries overall.  Engagement of callers with the telephone survey was not 
problematic, with only 6.6% of eligible callers (152/2320) declining to participate. In 
addition, the number of entries that were excluded due to inaccurate or incomplete records 
was only 6% (140/2320).  
Conclusions: 
The use of NPIS services significantly reduced ED referrals from primary healthcare 
services. The estimated resulting savings from this alone exceed the current total NPIS 
budget, demonstrating the cost-effectiveness of the service.  Further studies are needed to 
evaluate other benefits, such as improvements in quality of care, reductions in morbidity, 
mortality or hospital inpatient stay and avoidance of hospital admission in those referred to 
the ED, referral to other health services and productivity loss related to unnecessary health 
care. 
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 Table 1: Source of telephone enquiries: 
 
Source Calls (n) 
NHS 111, NHS 24 or NHS Direct* 1248 
General Practitioner/Primary Care 449 
Ambulance 226 
HM Prison 54 
Walk in Centre 14 
Community Pharmacist 12 
Other 7 
Support Services 5 
Police 4 
School 4 
Dental Establishment 2 
Nursing/Care Home 2 
Veterinary Practice 1 
Total 2028 
*Public health advice telephone services 
 
  
 Table: 2 Changes to initial planned referrals following NPIS telephone advice: 
 
 Initial planned 
referrals 
Referrals following NPIS telephone consultation 
Emergency 
Department 
General 
Practitioner 
Pharmacy Home care 
Emergency 
Department 
 
1178 (58.1%) 640  
(31.6%) 
74 
(3.6%) 
2 
(0.2%) 
462 
(22.8%) 
General 
Practitioner 
 
515 (25.4%) 119 
(5.9%) 
114 
(5.6%) 
1 
(0.05%) 
281 
(13.9%) 
Pharmacy 
 
59 (2.9%) 5  
(0.2%) 
5 
(0.2%) 
3 
(0.15%) 
46 
(2.3%) 
Home care 
 
276 (13.6%) 55 
(2.8%) 
12 
(0.6%) 
0 209 
(10.3%) 
Final number of 
referrals 
2028 819 
(40.4%) 
205 
(10.1%) 
6 
(0.3%) 
998 
(49.2%) 
Absolute 
change (CI) 
 -17.7% 
(14.6, 20.7) 
-15.3% 
(12.9, 17.6) 
-2.6% 
(1.8, 3.5) 
+35.6% 
(32.9, 38.2) 
P value*  <0.0001 <0.0001 <0.0001 <0.0001 
*Chi-square test with Yates continuity correction. 
 
 
Table: 3 Analysis of telephone enquiry data according to time received and PSS. Note that negative value reflects increased ED referrals 
following NPIS telephone consultation. 
 
 Surveyed calls 
(n) 
ED referrals 
avoided (n) 
% Annual calls 
(n) 
Annual ED 
referrals 
avoided (n) 
Savings (£) 
(a) PSS 0 or unclassified, 
office hours 
796 189 23.7% 11080 2626  £             411,337  
(b) PSS 0 or unclassified, 
out of hours 
797 141 17.7% 14827 2624  £             411,023 
       
(c) PSS ≥1, office hours 238 33 13.9% 3463 481  £               75,344  
       
(d) PSS ≥1, out of hours 197 -4 -2.0% 4489 -90 -£               14,098  
       
Totals* 2028 359 17.7% 33859 5641  £             883,606  
       
Overall** 2028 359 17.7% 33859 5994  £             938,900  
* Totals of groups A to D when calculated separately. 
** Overall surveyed calls and ED referrals avoided prior to correction as per PSS/time of call (*). 
 
  
Table: 4 Changes to initial planned referrals following TOXBASE® consultation:  
 
 Initial planned 
referrals 
Referrals following TOXBASE® consultation 
Emergency 
Department 
General 
Practitioner 
Pharmacy Home care 
Emergency 
Department 
 
410 (48.2%) 310 
(36.4%) 
31 
(3.6%) 
5 
(0.6%) 
64 
(7.5%) 
General 
Practitioner 
 
175 (20.6%) 19 
(2.2%) 
115 
(13.5%) 
0 41 
(4.8%) 
Pharmacy 
 
19 (2.2%) 3 
(0.4%) 
2 
(0.2%) 
6 
(0.7%) 
8 
(0.9%) 
Home care 
 
247 (29%) 9 
(1%) 
12 
(1.4%) 
2 
(0.2%) 
224 
(26.3%) 
Final number of 
referrals 
851 341 
(40%) 
160 
(18.8%) 
13 
(1.5%) 
337 
(39.6%) 
Absolute 
change (CI) 
 -8.1% 
(3.3, 12.9) 
-1.8% 
(-2.1, 5.6) 
-0.7% 
(-0.7, 2.2) 
+10.6% 
(6, 15) 
P value*  <0.0001 NS NS <0.0001 
*Chi-square test with Yates continuity correction. 
Supplementary material: Telephone survey script and TOXBASE pop-up questions 
 
 
(A) NPIS Telephone survey script for primary care enquirers 
 
Thank you for calling the NPIS. 
We are currently running a service evaluation of the NPIS advisory service. 
This consists of only two short questions; one at the beginning and one at the end of this 
consultation. 
Would you be happy to participate?  
 
If yes, then present the following question: 
 
1-         If the NPIS telephone advice service was unavailable which of the following options 
would best represent your management of the case you are calling about? 
 
 Attend a hospital emergency department                   XX1A 
 Attend/follow up at a GP surgery                                XX1B 
 Attend a pharmacy                                                      XX1C 
 Home care/no treatment                                             XX1D 
 
Next question following advice: 
 
2-         Following the telephone advice received from the NPIS which of the following 
options would best represent your planned management now: 
 
 Attend a hospital emergency department                   XX2A 
 Attend/follow up at a GP surgery                                XX2B 
 Attend a pharmacy                                                      XX2C 
 Home care/no treatment                                             XX2D 
 
Thank you for your kind cooperation. 
 
TOXBASE survey 
 
(b) Questions were presented to registered primary care users via pop up box on 
TOXBASE: 
 
Before you read TOXBASE, please tell us how you would manage your patient? 
 
Options 
 
 Attend a hospital emergency department                    
 Attend/follow up at a GP surgery                                 
 Attend a pharmacy                                                       
 Home care/no treatment                                              
 
 
After reading TOXBASE, please tell us how you will now manage your patient? 
 
Options 
 
 Attend a hospital emergency department                   
 Attend/follow up at a GP surgery                                 
 Attend a pharmacy                                                       
 Home care/no treatment                                              
 
 
 
